'Nontraditional' CRO services diversifying revenue streams, says analyst

According to KPMG research, the top 10 CROs represent more than half the market. (Image: iStock/pojoslaw)

Currently, the top ten CROs represent more than half the market, and as the industry continues to grow analysts suggest companies expand revenue streams through “nontraditional” services offerings.

The project is titled “Developing an ethical, sustainable, human sensory neuron cell culture model for use in therapeutic pain research,” or DRGNET. (Image: iStock/bodym)

Metrion: research consortium aiming to reduce animal studies, facilitate new drug development

The RNA Institute focusing on developing tools and analytics for RNA therapeutics. (Image: iStock/ktsimage)

AMRI partners to advance RNA-based therapeutics, research tools

iStock/idildemir

API firm Unimark Remedies warned by US FDA about Indian plants

70% of new drugs registered in Europe in 2015 were tested in phase II-III clinical trials in Russia. (Image: iStock/eyegelb)

Marken expands capabilities with new pharma license at Moscow depot

The cloud-based data management system will allow sponsors to immediately access clinical trial data. (Image: iStock/lukutin77)

New Ph I-IV data management system to provide access to clinical trial data in real time

See More Headlines

Clinical Development

(Image: iStock)

Frenova Renal Research expands in Durham, NC

The transaction is expected to close in the fourth quarter of 2016. (Image: iStock/pichet_w)

Bioclinica acquired by private equity firm

(Image: iStock/Alexander Traksel)

CRO BioPharma Services acquires BLS assets, expands analytical services

See More in Clinical Development

Commercial Services

(Image: iStock/Pogonici)

Translation company completes third acquisition amid trial globalization

Researchers have developed a new system that permits database queries for genome-wide association studies, but reduces the chances of privacy compromises to almost zero. (Illustration: Christine Daniloff/MIT)

Overcoming privacy concerns in medical research databases

(Image: iStock/ajus)

Purdue Pharma joins health policy research organization

See More in Commercial Services

Contract Manufacturing

iStock/AlexRaths

Pfizer to buy AstraZeneca's antibiotic business in deal worth up to $1.5bn

Image: The Eagle Blister Machine from MHI

'Americanizing' a Japanese blister machine

Siegfried's St Vulbas site in France - acquired from BASF last year (source Siegfried)

BASF API biz boosts Siegfried in H1, but IT integration costs hit profits

See More in Contract Manufacturing

Preclinical Research

CRISPR-Cas9 is a gene editing tool that has implications in both disease treatment and drug discovery. (Image: iStock)

AMRI licenses CRISPR-Cas9 gene editing tech for drug discovery

The immuno-oncology market is expected to see annual revenues of up to $40bn by 2020. (Image: iStock/TanawatPontchour)

Crown Bio adds services at newly expanded oncology center

(Image: iStock/verdateo)

Charles River partners with Milner Therapeutics Institute and Consortium

See More in Preclinical Research

Popular News

The transaction is expected to close in the fourth quarter of 2016. (Image: iStock/pichet_w)

Bioclinica acquired by private equity firm

According to KPMG research, the top 10 CROs represent more than half the market. (Image: iStock/pojoslaw)

'Nontraditional' CRO services diversifying revenue streams, says analyst

Adaptive designs allow for modifications during a study, without compromising integrity or validity. (Image: iStock/Incrivelfotos)

Adaptive designs: patient value and commercial benefits

Galleries

Videos

Audio

Latest Products

See more products